Using molecular screening of small molecule libraries, a team of researchers has been able to identify fluoxetine (commonly known as Prozac), a selective serotonin reuptake inhibitor, as a potent inhibitor of coxsackievirus replication.
Using molecular screening of small molecule libraries, a team of researchers has been able to identify fluoxetine (commonly known as Prozac), a selective serotonin reuptake inhibitor, as a potent inhibitor of coxsackievirus replication.